Radiopharm Theranostics Ltd (RADX)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.74
Day's range
$4.98

Radiopharm Theranostics Ltd Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 51.00 M $670.50 K   0.00% 129,474.49%
HSBC HOLDINGS PLC 08/14/2026 62.19 K $253.73 K   1.33% 157.88%
REGAL PARTNERS LTD 08/14/2026 40.14 K $168.18 K   0.00% 101.90%
PNC FINANCIAL SERVICES GROUP, INC. 08/07/2026 20.00 K $83.80 K   25.00% 50.77%
UBS GROUP AG 08/13/2026 1.51 K $6.31 K   -49.77% 3.83%
INTEGRATED WEALTH CONCEPTS LLC 08/12/2026 1.31 K $5.49 K   100.00% 3.33%
RHUMBLINE ADVISERS 08/12/2026 195 $817   61.16% 0.50%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 0 $0   -100.00% 0.00%

Radiopharm Theranostics Ltd institutional Ownership - FAQ's

During the previous two years, 8 institutional investors and hedge funds held shares of Radiopharm Theranostics Ltd. The most heavily invested institutionals were:

Stonepine Capital Management, LLC: 51 M

HSBC HOLDINGS PLC: 62,188

Regal Partners Ltd: 40,138

PNC FINANCIAL SERVICES GROUP, INC.: 20,000

UBS Group AG: 1,507

Integrated Wealth Concepts LLC: 1,310

129,792.68% of Radiopharm Theranostics Ltd stock is owned by institutional investors.

Institutional investors have bought a total of 51.13 M shares in the last 24 months. This purchase volume represents approximately $252.56 M in transactions.